Anthony Moorman, PhD, is a Professor of Genetic Epidemiology at the Newcastle University, Newcastle upon Tyne, UK. Prof. Moorman obtained his bachelor’s degree in genetics from Sheffield University, Sheffield, UK, in 1991, followed by a master’s in computer science from Birkbeck College, University of London, London, UK, in 1997. He then moved to Leeds to complete his doctorate in epidemiology at the University of Leeds, Leeds, UK, in 2001. Prof. Moorman then worked at the Leukemia Research Cytogenetics Group based in Cancer Sciences Division of the University of Southampton, Southampton, UK, until 2007, before being appointed as Professor of Genetic Epidemiology at Newcastle University.
Prof. Moorman holds International Membership of the American Society of Hematology as well as membership for the International BFM Study Group. He is also a committee member for the Bloodwise Childhood Leukemia Cell Bank Steering Committee.
Speaking on the cytogenetics of acute lymphoblastic leukemia
Prof. Moorman’s research interests primarily lie in investigating the genomic landscape of acute lymphoblastic leukemia (ALL) in both adult and pediatric patients. His recent contributions have included the characterisation of the genomic landscape of CRLF2-rearranged ALL. Prof. Moorman has also been extensively involved in clinical trials assessing treatment protocols, namely the UKALL2003 trial.